Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in MESO — Mesoblast Ltd

CIK 72971 SAN FRANCISCO, CA
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$258,328
-$19,942 QoQ
Shares Held
19,093
+5.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 72 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. MESO ranks #231 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in MESO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $258,328 19,093
2026-03-31 $278,270 18,093
2025-12-31 $326,397 18,093
2025-09-30 $418,908 26,003
2025-06-30 $275,898 25,335
2025-03-31 $332,492 26,642
2024-12-31 $300,722 15,188
2024-09-30 $223,294 27,331
2024-06-30 $362,257 53,195
2024-03-31 $296,662 59,214
2023-12-31 $123,379 112,163
2023-09-30 $59,971 48,757
2023-06-30 $206,498 52,813
2023-03-31 $112,077 34,066
2022-12-31 $13,386 4,600
2022-09-30 $11,730 4,600
2022-06-30 $10,212 4,600
2022-03-31 $19,412 4,600
2021-12-31 $13,440 2,800
2021-09-30 $691 115
2021-03-31 $80,053 9,680
2020-12-31 $61,679 7,265
2020-09-30 $166,435 8,953